These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 2942638)

  • 21. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
    Alexander BS; Wood MD
    J Pharm Pharmacol; 1988 Dec; 40(12):888-91. PubMed ID: 2907586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of 5-hydroxytryptamine 1A-like binding sites in human ganglioneuroblastoma.
    Pranzatelli MR; Balletti J
    Neurosci Lett; 1991 Oct; 132(1):117-20. PubMed ID: 1838579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a [3H]-5-hydroxytryptamine binding site in rabbit caudate nucleus that differs from the 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D subtypes.
    Xiong WC; Nelson DL
    Life Sci; 1989; 45(16):1433-42. PubMed ID: 2811600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
    Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus.
    Markstein R; Hoyer D; Engel G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):335-41. PubMed ID: 2945992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations].
    Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
    Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M
    Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; Vilaró MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photoaffinity labelling and solubilization on the central 5-HT1A receptor binding site.
    Gozlan H; Emerit MB; el Mestikawy S; Cossery JM; Marquet A; Besselievre R; Hamon M
    J Recept Res; 1987; 7(1-4):195-221. PubMed ID: 2957498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.
    Pazos A; Hoyer D; Palacios JM
    Eur J Pharmacol; 1984 Nov; 106(3):539-46. PubMed ID: 6519175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible blockade of central 5-HT1A receptor binding sites by the photoaffinity probe 8-methoxy-3'-NAP-amino-PAT.
    Emerit MB; Gozlan H; Marquet A; Hamon M
    Eur J Pharmacol; 1986 Aug; 127(1-2):67-81. PubMed ID: 2944752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB; Battaglia G; Creese I
    Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB; Miquel MC; Gozlan H; Hamon M
    J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Audinot-Bouchez V; Lochon S; Lavielle G; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):682-8. PubMed ID: 9205951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.